Literature DB >> 30975925

Intense rehabilitation therapy produces very large gains in chronic stroke.

Steven C Cramer1.   

Abstract

Entities:  

Keywords:  disability; function; nihilism; rehabilitation; stroke

Mesh：

Year:  2019        PMID： 30975925      PMCID： PMC6812537          DOI： 10.1136/jnnp-2019-320441

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Neural function, injury, and stroke subtype predict treatment gains after stroke.

Authors:  Erin Burke Quinlan; Lucy Dodakian; Jill See; Alison McKenzie; Vu Le; Mike Wojnowicz; Babak Shahbaba; Steven C Cramer
Journal:  Ann Neurol       Date:  2014-12-04       Impact factor: 10.422

2.  A Home-Based Telerehabilitation Program for Patients With Stroke.

Authors:  Lucy Dodakian; Alison L McKenzie; Vu Le; Jill See; Kristin Pearson-Fuhrhop; Erin Burke Quinlan; Robert J Zhou; Renee Augsberger; Xuan A Tran; Nizan Friedman; David J Reinkensmeyer; Steven C Cramer
Journal:  Neurorehabil Neural Repair       Date:  2017-10-26       Impact factor: 3.919

3.  Is more better? Using metadata to explore dose-response relationships in stroke rehabilitation.

Authors:  Keith R Lohse; Catherine E Lang; Lara A Boyd
Journal:  Stroke       Date:  2014-05-27       Impact factor: 10.170

4.  Dose response of task-specific upper limb training in people at least 6 months poststroke: A phase II, single-blind, randomized, controlled trial.

Authors:  Catherine E Lang; Michael J Strube; Marghuretta D Bland; Kimberly J Waddell; Kendra M Cherry-Allen; Randolph J Nudo; Alexander W Dromerick; Rebecca L Birkenmeier
Journal:  Ann Neurol       Date:  2016-08-16       Impact factor: 11.274
  4 in total
  1 in total

1.  Bilateral motor priming for post stroke upper extremity hemiparesis: A randomized pilot study.

Authors:  Mary Ellen Stoykov; Erin King; Fabian J David; Amanda Vatinno; Louis Fogg; Daniel M Corcos
Journal:  Restor Neurol Neurosci       Date:  2020       Impact factor: 2.406
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.